Buscar resultados de ensayos clínicos
Huntington Disease - 35 Studies Found
Estado | Estudiar |
Completed |
Nombre del estudio: Study of Huntington Patients in Connection With European Huntington's Disease Network (EHDN) Condición: Huntington Disease Fecha: 2012-03-11 |
Completed |
Nombre del estudio: Working Memory Training in Huntington's Disease Condición: Huntington's Disease Fecha: 2016-09-30 Intervenciones: Behavioral: Cogmed QM The intervention consisted of 25 Cogmed sessions, typically completed over a five |
Completed |
Nombre del estudio: Family Health After Predictive Huntington Disease (HD) Testing Condición: Huntington Disease Fecha: 2004-01-02 Intervenciones: Genetic: Mutation in the gene |
Completed |
Nombre del estudio: Ursodiol in Huntington's Disease Condición: Huntington Disease Fecha: 2007-08-08 Intervenciones:
|
Recruiting |
Nombre del estudio: Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of IONIS-HTTRx in Patients With Early Manifest Huntington's Disease Condición: Huntington's Disease Fecha: 2015-08-01 Intervenciones:
|
Recruiting |
Nombre del estudio: Deep Brain Stimulation (DBS) of the Globus Pallidus (GP) in Huntington's Disease (HD) Condición: Huntington Disease Fecha: 2015-08-27 Intervenciones: Device: ACTIVA® PC neurostimulator (Model 37601) the stimulator in the stimulation group will be tu |
Completed |
Nombre del estudio: Premanifest Huntington's Disease: Creatine Safety & Tolerability Extension Study Condición: Huntington's Disease Fecha: 2011-08-04 Intervenciones: Drug: Creatine Monohydrate Up to 30 grams daily creatine monohydrate |
Terminated |
Nombre del estudio: Coenzyme Q10 in Huntington's Disease (HD) Condición: Huntington's Disease Fecha: 2008-02-04 Intervenciones:
|
Completed |
Nombre del estudio: Premanifest Huntington's Disease Extension Study II: Creatine Safety & Tolerability Condición: Huntington's Disease Fecha: 2011-08-04 Intervenciones: Drug: Creatine monohydrate Up to 30 grams daily creatine monohydrate |
Not yet recruiting |
Nombre del estudio: Safety Evaluation of Cellavita HD Administered Intravenously in Participants With Huntington's Disease Condición: Huntington Disease Fecha: 2016-03-11 Intervenciones:
|